TITLE

Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus

AUTHOR(S)
Bellini, Carlo; Campone, Francesco; Serra, Giovanni
PUB. DATE
June 2006
SOURCE
CMAJ: Canadian Medical Association Journal;6/20/2006, Vol. 174 Issue 13, p1843
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Patent ductus arteriosus is one of the most common congenital abnormalities found in premature infants. Ibuprofen, a nonsteroidal drug that is commonly used as an antipyretic, analgesic and anti-inflammatory agent, is also used to induce closure of symptomatic patent ductus arteriosus in preterm infants. Recently, we gave L-lysine ibuprofen to a preterm infant with respiratory distress to induce closure of a patent ductus arteriosus, and the infant experienced pulmonary hypertension. Only 3 cases of pulmonary hypertension following early administration of an ibuprofen solution buffered with tromethamine have previously been reported. However, this severe side effect has never been observed in multicentre, randomized, double-blind controlled trials, nor in recent reviews or meta-analyses of L-lysine ibuprofen use.
ACCESSION #
21115939

 

Related Articles

  • Large patent ductus arteriosus in an adult complicated by pulmonary endarteritis and embolic lung abscess. Navaratnarajah, Manoraj; Mensah, Kwabena; Balakrishnan, Mahesh; Raja, Shahzad G.; Bahrami, Toufan // Heart International;2011, Vol. 6 Issue 2, p57 

    Patent ductus arteriosus in the adult is an extremely rare clinical phenomenon. We report the case of a 34-year old man who developed pulmonary endarteritis and subsequent embolic lung abscess secondary to a large patent ductus arteriosus. This brief report also provides an overview of the...

  • Recanalization of the Patent Ductus Arteriosus: Report of an Interesting Case. Hutchinson, Richard G. // Angiology;Oct1975, Vol. 26 Issue 9, p698 

    Looks into the recanalization of patent ductus arteriosus. Association of the correction of the uncomplicated defect in the hands of physicians with an exceedingly low mortality rate; Number of cases examined for the study; Revelation of the prominence of the main pulmonary artery, possible...

  • Successful Transcatheter Closure of a Patent Ductus Arteriosus: Using Two Gianturco Coils in a 41-Year-Old Woman. Shamsham, Fadi; Tak Kwan; Safi, Arshad M.; Clark, Luther T. // Angiology;Jun1999, Vol. 50 Issue 6, p519 

    Patent ductus arteriosus (PDA) is a form of congenital heart disease uncommonly diagnosed in adult patients. Transcatheter closure of PDA has been widely used in children. However, the experience is limited in adults especially with use of Gianturco coils. The authors describe a case of...

  • THE EXTRAPLEURAL LIGATION OF PATENT DUCTUS ARTERIOSUS IN THE SERIOUSLY ILL INFANT. Yao, J.K.Y.; Mustard, W.T. // Angiology;Nov1969, Vol. 20 Issue 10, p585 

    In the occasional infant with pulmonary problems (e.g., pneumonia) with concomitant heart failure as a result of a large patent ductus, we feel that closure of the ductus can be more safely accomplished without entering the pleural cavity. The postoperative course is also smoother.

  • Thirty years after percutaneous closure of patent ductus arteriosus. Borges, A.C.; Gliech, V.; Baumann, G. // Heart;Jun2003, Vol. 89 Issue 6, p650 

    Describes the case of a 68 year old woman presenting with complications 30 years after undergoing percutaneous closure of patent ductus arteriosus. Well preservation of lung and renal function; Results of an angiogram of the aorta.

  • Patent duktus arteriozusun perkütan yolla kapatılması: Üçüncü basamak bir merkezin deneyimi. Kaya, Hasan; Ertaş, Faruk; Polat, Nihat; Yıldız, Abdulkadir; Akıl, Mehmet Ata; Soydinç, M. Serdar; Alan, Sait; Ülgen, M. Sıddık // Dicle Medical Journal / Dicle Tip Dergisi;2013, Vol. 40 Issue 2, p258 

    Objective: We sought to evaluate our clinical experience and short-term results of percutaneous closure of patent ductus arteriosus (PDA). Methods: We studied 20 patients (17 female, mean age 24±8 years) undergoing percutaneous closure of PDA between March 2010-March 2013 in our clinic....

  • Transcatheter Closure of a Large Patent Ductus Arteriosus in a Young Child Using the Amplatzer Duct Occluder. Jan, S.-L.; Hwang, B.; Fu, Y.-C.; Chi, C.-S. // Pediatric Cardiology;Sep/Oct2005, Vol. 26 Issue 5, p703 

    The Amplatzer duct occluder (ADO) provides a safe and effective therapy for patients with moderate- to large-sized patent ductus arteriosus (PDA), but there have been few reports of transcatheter closure of very large PDAs in young children and infants. We report a successful transcatheter...

  • Patent ductus arteriosus: pathophysiology and management. Hermes-DeSantis, E. R.; Clyman, R. I. // Journal of Perinatology;May2006 Supplement, Vol. 26, pS14 

    Patent ductus arteriosus (PDA) in preterm newborns prior to 28 weeks of gestation has led to many challenges regarding the type and timing of treatment regimens. A PDA results in increased pulmonary blood flow and redistribution of flow to other organs. Several co-morbidities (i.e., necrotizing...

  • Vascular plug for PDA closure found effective in children.  // Cardiology Today;Sep2013, Vol. 16 Issue 9, p16 

    The article focuses on the findings of a retrospective study which revealed the safe and effective use of an Amplatzer duct occluder for the closure of medium- and small-sized patent ductus arteriosus in children and symptomatic infants.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics